Impact of Antibiotic Use During Pregnancy on Premature Infants
Introduction
The use of antibiotics during pregnancy is sometimes unavoidable. Recent research published in the Journal of Pediatrics examines how antibiotic use affects the health of premature infants, who are particularly vulnerable even within neonatal intensive care units.
Vulnerability of Premature Infants
Infants born prematurely are at high risk for various health issues. Approximately 33% of babies born before 32 weeks of gestation develop late-onset sepsis (LOS), an infection of the bloodstream caused by bacteria. Less frequently, about 7% of these infants suffer from necrotizing enterocolitis (NEC), a severe condition where sections of the bowel die and which has a high mortality rate. Previous studies have indicated that prolonged antibiotic treatment from birth may heighten the risk of developing these conditions or lead to mortality.
Antibiotics and Fetal Microbial Populations
There is growing concern that infections in infants may be linked to antibiotic resistance stemming from medications taken by mothers during pregnancy. This led a research team in the United States to investigate whether fetal exposure to antibiotics could result in an increased incidence of bacterial infections post-birth, particularly LOS and NEC, in premature infants.
Study Overview
The research team analyzed data from 580 infants born before 32 weeks of gestation, who were admitted to one of three level-III neonatal intensive care units located in Ohio or Alabama. The infants were monitored for up to 120 days or until discharge, transfer, or death. The findings revealed that 21.3% of these infants experienced either NEC (7.5%), LOS (11.1%), or death (9.6%). Factors such as birth weight, gestational age, sex, race, or breastfeeding duration did not influence these outcomes.
Protective Effects of Antibiotics During Pregnancy
When the research team assessed the correlation between antibiotic use during pregnancy and the incidence of NEC, LOS, or death, they found that 62.4% of infants had been exposed to at least one antibiotic prior to birth. Antibiotics administered during pregnancy were defined as those given within 72 hours of delivery. Mothers who received antibiotics at delivery or during cesarean sections were excluded from this analysis.
Surprisingly, the study revealed that antibiotic use during pregnancy reduced the risk of NEC and infant mortality by a factor of three. However, there was a non-significant 1.6-fold increase in the risk of LOS, a finding that warrants further investigation.
Postnatal Antibiotic Exposure and Risks
The study also examined the effects of antibiotics given to infants immediately after birth. It was found that 23.2% of the infants had a high level of postnatal antibiotic exposure, which was defined as receiving antibiotics for more than five continuous days from birth. These infants were also more likely to have been exposed to antibiotics in utero.
The research highlighted that high postnatal antibiotic exposure increased the risk of death by three-fold, although it did not affect the incidence of NEC or LOS. There is a possibility that prenatal antibiotic exposure contributed to antibiotic-resistant infections in this subgroup of infants.
Future Research Directions
This study underscores the importance of comprehending how antibiotics influence the interactions between maternal and infant microbial populations. Such insights will be crucial for clinicians when determining the appropriate antibiotics for use in vulnerable premature infants. The authors also note that microbial populations may differ significantly based on geographical, temporal, and ethnic factors, suggesting that these findings may not be universally applicable.
Conclusion
The research conducted by Reed et al. emphasizes the complexity of antibiotic impacts on neonatal health, particularly in premature infants. Further studies are necessary to explore the effects of antibiotics on microbial populations and to refine treatment protocols for this at-risk population.
References
Reed B, et al. The impact of maternal antibiotics on neonatal disease. J Pediatr. 2018. 197: 97-103.
Related Topics
– New Method to Predict Retinopathy of Prematurity in Infants
– Does Caffeine Cause Osteopenia in Premature Infants?
– Preterm infant microbiome: A new diagnostic tool for growth-rate prediction?